One of the key areas of cancer research is to find more methods for personalizing cancer research. This article talks about some interesting leads in this area, including the use of cancer vaccines and targeted therapies to help people who have lung cancer, especially those who have had surgery; such treatment can help people avoid a recurrence of the cancer (link to article):
"Personalizing therapy is the key strategy for longer and better survival in lung cancer," said Prof Paris Kosmidis, head of the second Medical Oncology Department at Hygeia Hospital in Athens, Greece. "This is particularly important for early stage disease when following surgery, decisions about preventive therapy are based on specific prognostic and predictive factors."
At the conference, researchers will describe a gene signature that might predict which patients will benefit from the treatment. "Because the benefits of vaccination will be limited to a subgroup of patients, strategies to define these patients by means of biomarkers such as a genetic signature are of major clinical relevance, as only these patients might be candidates for vaccination in the future,” said Weder.
As we proceed on research, science keeps on finding weapons in the fight cancers; and one of the most worrisome issues for a patient who has had the removal of their cancer is whether the cancer will come back - this research points to indicators about how to prevent the delay.
No comments:
Post a Comment